Menu Search
Equities

Mckesson Corp

MCK:NYQ

Mckesson Corp

Actions
Consumer Staples Personal Care, Drug and Grocery Stores
  • Price (USD)622.89
  • Today's Change-5.38 / -0.86%
  • Shares traded255.56k
  • 1 Year change+36.17%
  • Beta0.4705
Data delayed at least 15 minutes, as of Nov 22 2024 20:11 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

McKesson Corporation is a provider of diversified healthcare services. The Company is engaged in advancing health outcomes for patients everywhere. Its U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar, and over the counter (OTC) pharmaceutical drugs and other healthcare-related products in the United States. Its Prescription Technology Solutions segment helps solve medication access, affordability, and adherence challenges for patients by working across healthcare to connect patients, pharmacies, providers, pharmacy benefit managers, health plans, and biopharma companies. Its Medical-Surgical Solutions segment provides medical-surgical supply distribution, logistics, and other services to healthcare providers, including physician offices, surgery centers, nursing homes, hospital reference labs, and home healthcare agencies. Its International segment provides distribution and services to wholesale, institutional, and retail customers in Europe and Canada.

  • Revenue in USD (TTM)330.19bn
  • Net income in USD2.54bn
  • Incorporated1994
  • Employees45.00k
  • Location
    Mckesson Corp6555 State Highway 161IRVING 75039United StatesUSA
  • Phone+1 (972) 446-4800
  • Fax+1 (302) 636-5454
  • Websitehttps://www.mckesson.com/
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status		MCK:NYQ since
announced		Transaction
value
Community Oncology Revitalization Enterprise Ventures LLCAnnounced26 Aug 202426 Aug 2024Announced12.81%2.49bn
Compile IncDeal completed04 Jan 202404 Jan 2024Deal completed29.68%--
Data delayed at least 15 minutes, as of Nov 22 2024 20:11 GMT.

Institutional shareholders

33.52%Per cent of shares held by top holders
HolderShares% Held
The Vanguard Group, Inc.as of 30 Sep 202411.46m8.84%
BlackRock Fund Advisorsas of 30 Sep 20246.75m5.21%
SSgA Funds Management, Inc.as of 30 Sep 20245.88m4.54%
Massachusetts Financial Services Co.as of 30 Sep 20244.94m3.81%
JPMorgan Investment Management, Inc.as of 30 Sep 20242.97m2.29%
Geode Capital Management LLCas of 30 Sep 20242.65m2.05%
T. Rowe Price Investment Management, Inc.as of 30 Sep 20242.62m2.02%
Norges Bank Investment Managementas of 30 Jun 20242.28m1.76%
Putnam Investment Management LLCas of 30 Sep 20242.10m1.62%
Fidelity Management & Research Co. LLCas of 30 Sep 20241.80m1.39%
More ▼
Data from 30 Jun 2024 - 30 Sep 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.